Cargando…
Rho/SRF Inhibitor Modulates Mitochondrial Functions
CCG-1423 is a Rho A pathway inhibitor that has been reported to inhibit Rho/SRF-mediated transcriptional regulation. Serum response factor and its cofactors, which include ternary complex factors and myocardin-related transcription factors, regulate various cellular functions. In this study, we obse...
Autores principales: | Patyal, Pankaj, Nguyen, Bachkhoa, Zhang, Xiaomin, Azhar, Gohar, Ameer, Fathima S., Verma, Ambika, Crane, Jasmine, KC, Grishma, Che, Yingni, Wei, Jeanne Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570101/ https://www.ncbi.nlm.nih.gov/pubmed/36232837 http://dx.doi.org/10.3390/ijms231911536 |
Ejemplares similares
-
P. gingivalis-LPS Induces Mitochondrial Dysfunction Mediated by Neuroinflammation through Oxidative Stress
por: Verma, Ambika, et al.
Publicado: (2023) -
A Study of C2C12 Myoblast Bioenergetics in Response to the CCG-1423 Rho A Inhibitor
por: Nguyen, Bachkhoa, et al.
Publicado: (2021) -
Sirtuin-1 isoforms differentially regulate mitochondrial function
por: Zhang, Xiaomin, et al.
Publicado: (2021) -
LOW GLUCOSE ENHANCES THE CYTOPROTECTIVE EFFECT OF METFORMIN AGAINST DOXORUBICIN-INDUCED CYTOTOXICITY
por: Ameer, Fathima, et al.
Publicado: (2019) -
Correction to: Differential plasma protein expression after ingestion of essential amino acid-based dietary supplement versus whey protein in low physical functioning older adults
por: Azhar, Gohar, et al.
Publicado: (2023)